AKRO
Akero Therapeutics
AKRO
AKRO
Delisted
AKRO was delisted on the 8th of December, 2025.
254 hedge funds and large institutions have $4.92B invested in Akero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
7.01% more ownership
Funds ownership: 108.56% → 115.57% (+7%)
6% more funds holding
Funds holding: 239 → 254 (+15)
0% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 87
Holders
254
Holding in Top 10
16
Calls
$100M
Puts
$48.2M
Top Buyers
| 1 | +$187M | |
| 2 | +$118M | |
| 3 | +$106M | |
| 4 |
Holocene Advisors
New York
|
+$57.4M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$56.6M |
Top Sellers
| 1 | -$135M | |
| 2 | -$104M | |
| 3 | -$61.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$39.5M |
| 5 |
BlackRock
New York
|
-$25.4M |
